Longitudinal study on prevalence, incidence and persistence of SARS-CoV-2 antibodies in health care workers using home blood collection kits and a fully automated ELISA and ECLIA antibody assay

Overview

Acronym
LSPIPSA-HCW
Investigators
  • Dr. Keith Jarvi

    Mount Sinai Hospital

Contacts
  • Susan Lau

    Mount Sinai Hospital

General Design

Study design
Cohort
Start Year
2020
End Year
2022
General Information on Follow Up (profile, frequency)
Recruitment Target
  • Individuals
Number of Participants
1,720
Number of Participants with Biological Samples
1,720
Supplementary information about number of participants

Access

Availability of data and biosamples

Possible Access to Data
Possible Access to Biosamples
Other

Timeline

Populations

LSPIPSA-HCW - COVID-19 infected

Selection Criteria

Countries
  • Canada
Territory
Toronto
Health Status
  • COVID-19 positive and recovered

Sources of Recruitment

Specific Population
  • Clinic patients
Supplementary Information

Sample Size

Number of Participants
10
Number of Participants with Biological Samples
10

Data Collection Events

# Name Description Start End
0 LSPIPSA-HCW - COVID-19 infected - ELISA capillary blood samples 2020 (September) Ongoing
LSPIPSA-HCW - COVID-19 negative and untested

Selection Criteria

Countries
  • Canada
Territory
Toronto
Health Status
  • COVID-19 untested or previously negative

Sources of Recruitment

Specific Population
  • Members of an association
Supplementary Information

Sample Size

Number of Participants
10
Number of Participants with Biological Samples
10

Data Collection Events

# Name Description Start End
0 LSPIPSA-HCW - COVID-19 negative and untested - ELISA capillary blood samples 2020 (September) Ongoing
LSPIPSA-HCW - Longitudinal

Selection Criteria

Countries
  • Canada
Territory
Ontario
Other Criteria
Exclusion: Present symptoms compatible with COVID-19 infections and for those with confirmed COVID-19 positive had a negative NP swab test for COVID-19 (recovered from COVID-19)

Sources of Recruitment

Specific Population
  • Members of an association
Supplementary Information

Sample Size

Number of Participants
1,700
Number of Participants with Biological Samples
1,700

Individual Studies Included

Acronym Name Study design Participants Countries

Harmonization Projects Included

Acronym Name

Networks

Acronym Name Studies

Datasets

Name Type Data Collection Events Variables
Last Update: 2021-10-19 19:00